Tumor development, proliferation and metastasis are regulated by abnormal cellular signaling pathways, and genes in the phosphoinositide 3-kinase (PI3K)/Akt pathway are the most frequently altered in human cancers. This evidence concerns the gene AKT1 and cancer.